The independent source for health policy research, polling, and news.
421 - 440 of 3,741 Results
Pregnant women are being asked to make large cash payments months before they deliver their babies. Some patient advocates worry this billing practice allows providers to hold treatment hostage.
With Republicans now set to control the White House, Senate, and House of Representatives starting in January, their health agenda remains unclear. What is clear, however, is that just about anything could be on the table, from Medicare, Medicaid, and the Affordable Care Act, to drug prices and public health. Meanwhile, anti-abortion groups are preparing to fight the implementation of abortion rights ballot measures just passed by voters in seven states. Rachel Roubein of The Washington Post, Anna Edney of Bloomberg News, and Lauren Weber of The Washington Post join KFF Health News’ Julie Rovner to discuss these stories and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week that they think you should read, too.
Freedom of Information Act case targets HHS inspector general’s reviews of billions of dollars in health plan overpayments.
California this year completed its Medi-Cal expansion to include income-eligible residents regardless of their immigration status. This final installment of the “Faces of Medi-Cal” series profiles three of those newly eligible patients and how coverage has affected their health.
Medicare officials defend the use of home visits that often spot medical conditions that are never treated.
The new Trump administration is likely to reduce subsidies for Affordable Care Act insurance plans and roll back Medicaid coverage. Public health authorities worry that anti-vaccine activist Robert F. Kennedy Jr. will be empowered.
Vermont has one of the lowest uninsured rates in the U.S., even though its residents pay some of the highest health insurance costs. Still, most of its hospitals are losing money and patients often face long waits for care.
Democrats and conservatives are divided over whether the federal health program for people over 65 should be run almost entirely by the private sector. If Trump retakes the White House, the shift to Medicare Advantage may accelerate.
Health care has ebbed and surged as an election issue throughout the presidential campaign. Here are the ways some of the most consequential changes in health policies could hinge on whether Vice President Kamala Harris or former President Donald Trump wins.
Several Democratic-led states have expanded public insurance programs to cover immigrants in the U.S. regardless of legal status. Donald Trump is trying to blame Kamala Harris for the policies.
Conservative groups are working to undermine support for Montana’s Medicaid expansion ahead of a political fight over whether to keep the program.
For snakebite victims, antivenom is critical — and costly. It took more than $200,000 worth of antivenom to save one toddler’s life after he was bitten by a rattlesnake.
Medications such as methadone can cut the risk of a fatal opioid overdose in half. Medicaid covers the medication. But as state Medicaid programs reevaluated coverage of each enrollee following a pause in disenrollments during the covid-19 pandemic, some patients lost a crucial pillar of their sobriety.
Nineteen states are seeking to stall a Biden administration rule that would allow recipients of the Deferred Action for Childhood Arrivals program to enroll in ACA coverage and qualify for subsidies. DACA provides work authorization and temporary deportation protection to people brought to the U.S. as children without immigration paperwork.
The United States has made almost no progress in closing racial health disparities despite promises, research shows. The government, some critics argue, is often the underlying culprit.
The outcome of the upcoming presidential election could affect the number of insured Americans, the fate of premium-reducing subsidies, the shape of Medicaid, and the cost of coverage for tens of millions of people.
Criticism of prescription drug middlemen has intensified recently in the wake of a federal agency’s actions and legislative reform attempts. Georgia Republican Gov. Brian Kemp, though, vetoed a related bill that would have helped independent pharmacies, citing the unfunded cost of the move.
Health care hasn’t figured prominently on the campaign trail this fall. These voters wish it would.
Every year, Medicare officials encourage beneficiaries to shop around for their drug coverage. Few take the time. This year, it might be more important than ever.
© 2026 KFF